The capsid of SIV_MAC, HIV-2, or SIV_SM is sufficient to decrease HIV-1 transduction efficiency in a T cell-specific manner. by Massimo Pizzato (126906)

Decrease of goblet cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

Decrease of receptor detectibility following CRAD replication in a small fraction of cells. by Johan Rebetz (255622)

Inverse Relationship between IGF-1 induced Cyr61 upregulation and decreased E-cadherin and FOXO1 expression is confirmed in two cell lines. by Suren Sarkissyan (388555)

Decrease of Paneth cells in mice fed a high-fat diet (HFD). by June-Chul Lee (2850536)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

Simulated response to Ach at activated NALCN channels and decreased phosphodiesterase (PDE) activity in low glucose. by Leonid E. Fridlyand (2636968)

“…<p>(A) PM potentials (V_p); (B) [Ca²⁺]_c and [Ca²⁺]_ER; (C) Cytoplasmic cAMP and IP₃ concentrations. …”

Cell density-dependent decrease of phosphorylation of Akt and S6 ribosomal protein. by Noriyuki Kawabata (3391739)

PV1-treated mice exhibited a decrease in overall activation of T lymphocytes. by Pedro Henrique Papotto (791904)

GnRH responsive transcripts increase after ovariectomy and decrease after Antide treatment. by Maria K. Herndon (2212282)

Effects of vidarabine, V2E, V3E and V5E on cardiac fibrosis. by Kenji Suita (750993)

“…(A) Representative images of Masson-trichrome-stained ventricular muscle sections of WT mice treated with ISO (60 mg/kg/day) plus Vida (15 mg/kg/day), V2E (19.7 mg/kg/day), V3E (19.7 mg/kg/day) or V5E (19.7 mg/kg/day) for 7 days. …”

Primary samples from patients with AML: patient characteristics. by Anna Kalota (7415)

Subjects:

Cytotoxic effect of Eltrombopag on AML cells is dependent on dose and serum concentration. by Anna Kalota (7415)

Subjects:

Eltrombopag Does Not Significantly Affect Mitochondria Function and ATP Production. by Anna Kalota (7415)

Subjects:

Activation of apoptotic pathway in AML cells by Eltrombopag. by Anna Kalota (7415)

Subjects:

Eltrombopag completely inhibits S-phase DNA replication as measures by BrdU/7AAD staining in AML cells lines. by Anna Kalota (7415)

Subjects:

Modification of intracellular ROS level abrogates eltrombopag’s effect on AML cells. by Anna Kalota (7415)

Subjects:

MOLM14 cells incubated with Eltrombopag for 6 hours show higher expression of stress response genes. by Anna Kalota (7415)

Subjects:

Correlation between eltrombopag’s cytotoxic effect and ROS level at various drug doses and serum concentrations. by Anna Kalota (7415)

Subjects:

Mutation of <i>talB</i> in BAI3 results in a decrease of virulence partially complemented by the induction of <i>OsERF#123</i>. by Tuan T. Tran (5335004)